Neuroprotective actions of leptin facilitated through balancing mitochondrial morphology and improving mitochondrial function.
Autor: | Cheng Y; School of Psychology and Neuroscience, University of St Andrews, St Andrews, UK., Buchan M; School of Psychology and Neuroscience, University of St Andrews, St Andrews, UK., Vitanova K; School of Psychology and Neuroscience, University of St Andrews, St Andrews, UK., Aitken L; School of Biology, University of St Andrews, St Andrews, UK., Gunn-Moore FJ; School of Biology, University of St Andrews, St Andrews, UK., Ramsay RR; School of Biology, University of St Andrews, St Andrews, UK., Doherty G; School of Psychology and Neuroscience, University of St Andrews, St Andrews, UK. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of neurochemistry [J Neurochem] 2020 Sep; Vol. 155 (2), pp. 191-206. Date of Electronic Publication: 2020 Apr 08. |
DOI: | 10.1111/jnc.15003 |
Abstrakt: | Mitochondrial dysfunction has a recognised role in the progression of Alzheimer's disease (AD) pathophysiology. Cerebral perfusion becomes increasingly inefficient throughout ageing, leading to unbalanced mitochondrial dynamics. This effect is exaggerated by amyloid β (Aβ) and phosphorylated tau, two hallmark proteins of AD pathology. A neuroprotective role for the adipose-derived hormone, leptin, has been demonstrated in neuronal cells. However, its effects with relation to mitochondrial function in AD remain largely unknown. To address this question, we have used both a glucose-serum-deprived (CGSD) model of ischaemic stroke in SH-SY5Y cells and a Aβ (© 2020 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry.) |
Databáze: | MEDLINE |
Externí odkaz: |